High LAG-3 expression levels have been associated with poorer prognosis for renal cell carcinoma (RCC) [80], poor overall survival (OS) of patients with either high- or low-grade glioma [81], and low disease-free survival in patients with pancreatic cancer [82]. Here, LAG3 is linked to central nervous system cancer.